Denali Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-20,100
Closed -$455K 337
2019
Q3
$455K Hold
20,100
0.06% 185
2019
Q2
$507K Buy
+20,100
New +$540K 0.08% 145
2018
Q1
Sell
-2,300
Closed -$123K 284
2017
Q4
$123K Sell
2,300
-2,000
-47% -$94.4K 0.02% 128
2017
Q3
$185K Buy
+4,300
New +$204K 0.03% 112
2016
Q2
Sell
-16,300
Closed -$1.05M 311
2016
Q1
$1.05M Sell
16,300
-1,300
-7% -$86.2K 0.23% 93
2015
Q4
$1.26M Sell
17,600
-900
-5% -$66.6K 0.28% 80
2015
Q3
$1.42M Buy
18,500
+6,300
+52% +$508K 0.33% 79
2015
Q2
$904K Buy
+12,200
New +$878K 0.2% 101

Other funds holding MD

Denali Advisors's MD Position: Q4 2019 in Review

Denali Advisors sold out of Pediatrix Medical (MD) in Q4 2019, closing a stake of 20,100 shares — an estimated $455K sold.

Denali Advisors first reported a position in MD in Q2 2015 and held it in 8 quarters. The position peaked at $1.42M in Q3 2015. 258 funds tracked by Wall St. Rank hold MD as of Q4 2019.

  • Denali Advisors reported no remaining Pediatrix Medical position as of Q4 2019 after selling out during the quarter.
  • Denali Advisors sold 20,100 Pediatrix Medical shares in Q4 2019, an estimated $455K.
  • Denali Advisors first reported a position in Pediatrix Medical in Q2 2015 and held it in 8 quarters.
  • Denali Advisors's Pediatrix Medical position peaked at $1.42M in Q3 2015.
  • 258 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2019.

Based on Denali Advisors's 13F filing for Q4 2019, filed 30 Jan 2020.